Doing well...thanks. I am currently in ANTH and TZYM. TZYM has stated they are looking for a buyer. Only a 15 million market cap, with around 20 million book. Also, they have an agreement with Bristol-Myers Squibb using their technology that could provide for up to 80 million in milestone payments for each drug it is used on. ANTH just did an offering at .66 and should be starting a Phase III on blisibimod.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.